Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's Disease

被引:0
|
作者
Metcalfe-Roach, Avril [1 ,2 ]
Cirstea, Mihai S. [1 ,2 ]
Yu, Adam C. [3 ]
Ramay, Hena R. [4 ]
Coker, Olabisi [4 ]
Boroomand, Seti [5 ]
Kharazyan, Faezeh [5 ]
Martino, Davide [6 ]
Sycuro, Laura K. [4 ,7 ]
Appel-Cresswell, Silke [3 ,8 ]
Finlay, B. Brett [1 ,2 ,9 ]
机构
[1] Univ British Columbia, Dept Microbiol & Immunol, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada
[2] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada
[3] Univ British Columbia, Pacific Parkinsons Res Ctr, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada
[4] Univ Calgary, Int Microbiome Ctr, Cumming Sch Med, Calgary, AB, Canada
[5] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Borgland Family Brain Tissue & DNA Bank, Vancouver, BC, Canada
[6] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada
[7] Univ Calgary, Dept Microbiol Immunol & Infect Dis, 3330 Hosp Dr NW,Hlth Sci Ctr 1847, Calgary, AB T2N 4N1, Canada
[8] Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC, Canada
[9] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
metagenomics; microbiome; Parkinson's disease; METABOLISM; FATIGUE;
D O I
10.1002/mds.29959
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Parkinson's disease (PD) has been consistently linked to alterations within the gut microbiome. Objective: Our goal was to identify microbial features associated with PD incidence and progression. Methods: Metagenomic sequencing was used to characterize taxonomic and functional changes to the PD microbiome and to explore their relation to bacterial metabolites and disease progression. Motor and non-motor symptoms were tracked using Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and levodopa equivalent dose across <= 5 yearly study visits. Stool samples were collected at baseline for metagenomic sequencing (176 PD, 100 controls). Results: PD-derived stool samples had reduced intermicrobial connectivity and seven differentially abundant species compared to controls. A suite of bacterial functions differed between PD and controls, including depletion of carbohydrate degradation pathways and enrichment of ribosomal genes. Faecalibacterium prausnitzii-specific reads contributed significantly to more than half of all differentially abundant functional terms. A subset of disease-associated functional terms correlated with faster progression of MDS-UPDRS part IV and separated those with slow and fast progression with moderate accuracy within a random forest model (area under curve = 0.70). Most PD-associated microbial trends were stronger in those with symmetric motor symptoms. Conclusion: We provide further evidence that the PD microbiome is characterized by reduced intermicrobial communication and a shift to proteolytic metabolism in lieu of short-chain fatty acid production, and suggest that these microbial alterations may be relevant to disease progression. We also describe how our results support the existence of gut-first versus brain-first PD subtypes. (c) 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The gut microbiome in Parkinson's disease
    Bedarf, J. R.
    Hildebrand, F.
    Goeser, F.
    Bork, P.
    Wuellner, U.
    [J]. NERVENARZT, 2019, 90 (02): : 160 - 166
  • [2] Parkinson's Disease and the Gut Microbiome
    不详
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (04) : 213 - 213
  • [3] A metagenomic study of the gut microbiome in Behcet’s disease
    Zi Ye
    Ni Zhang
    Chunyan Wu
    Xinyuan Zhang
    Qingfeng Wang
    Xinyue Huang
    Liping Du
    Qingfeng Cao
    Jihong Tang
    Chunjiang Zhou
    Shengping Hou
    Yue He
    Qian Xu
    Xiao Xiong
    Aize Kijlstra
    Nan Qin
    Peizeng Yang
    [J]. Microbiome, 6
  • [4] A metagenomic study of the gut microbiome in PTB'S disease
    Ding, Xiudong
    Zhou, Jing
    Chai, Yinghui
    Yan, Zengkui
    Liu, Xin
    Dong, Yueming
    Mei, Xue
    Jiang, Ying
    Lei, Hong
    [J]. MICROBES AND INFECTION, 2022, 24 (02)
  • [5] A metagenomic study of the gut microbiome in Behcet's disease
    Ye, Zi
    Zhang, Ni
    Wu, Chunyan
    Zhang, Xinyuan
    Wang, Qingfeng
    Huang, Xinyue
    Du, Liping
    Cao, Qingfeng
    Tang, Jihong
    Zhou, Chunjiang
    Hou, Shengping
    He, Yue
    Xu, Qian
    Xiong, Xiao
    Kijlstra, Aize
    Qin, Nan
    Yang, Peizeng
    [J]. MICROBIOME, 2018, 6
  • [6] Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease
    Rosario, Dorines
    Bidkhori, Gholamreza
    Lee, Sunjae
    Bedarf, Janis
    Hildebrand, Falk
    Le Chatelier, Emmanuelle
    Uhlen, Mathias
    Ehrlich, Stanislav Dusko
    Proctor, Gordon
    Wuellner, Ullrich
    Mardinoglu, Adil
    Shoaie, Saeed
    [J]. CELL REPORTS, 2021, 34 (09):
  • [7] A Metagenomic Meta-analysis Reveals Functional Signatures of Health and Disease in the Human Gut Microbiome
    Armour, Courtney R.
    Nayfach, Stephen
    Pollard, Katherine S.
    Sharpton, Thomas J.
    [J]. MSYSTEMS, 2019, 4 (04)
  • [8] Practical considerations for large-scale gut microbiome studies
    Vandeputte, Doris
    Tito, Raul Y.
    Vanleeuwen, Rianne
    Falony, Gwen
    Raes, Jeroen
    [J]. FEMS MICROBIOLOGY REVIEWS, 2017, 41 : S154 - S167
  • [9] Implications of the Gut Microbiome in Parkinson's Disease
    Elfil, Mohamed
    Kamel, Serageldin
    Kandil, Mohamed
    Koo, Brian B.
    Schaefer, Sara M.
    [J]. MOVEMENT DISORDERS, 2020, 35 (06) : 921 - 933
  • [10] The Role of The Gut Microbiome in Parkinson's Disease
    Gallop, Amy
    Weagley, James
    Paracha, Saif-ur-Rahman
    Grossberg, George
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2021, 34 (04) : 253 - 262